Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103631814 | 10363181 | 4 | F | 20130729 | 20160817 | 20140805 | 20160819 | EXP | PHHY2013LB090634 | NOVARTIS | 59.00 | YR | F | Y | 0.00000 | 20160819 | CN | COUNTRY NOT SPECIFIED | LB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103631814 | 10363181 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG, UNK | S0045 | 21817 | 5 | MG | SOLUTION FOR INJECTION | ||||||
| 103631814 | 10363181 | 2 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 103631814 | 10363181 | 3 | C | EURO-D | 2 | Oral | 10000 U, WEEKLY | U | 0 | 10000 | DF | ||||||||
| 103631814 | 10363181 | 4 | C | CI-CAL D | 2 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | ||||||
| 103631814 | 10363181 | 5 | C | CI-CAL D | 2 | Oral | 1 DF, BID | U | 0 | 1 | DF | TABLET | BID | ||||||
| 103631814 | 10363181 | 6 | C | RABEC | 2 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | |||||||
| 103631814 | 10363181 | 7 | C | ASPICOT | ASPIRIN | 1 | Oral | 100 MG, UNK | U | 0 | 100 | MG | TABLET | ||||||
| 103631814 | 10363181 | 8 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103631814 | 10363181 | 1 | Osteoporosis |
| 103631814 | 10363181 | 2 | Product used for unknown indication |
| 103631814 | 10363181 | 3 | Product used for unknown indication |
| 103631814 | 10363181 | 4 | Product used for unknown indication |
| 103631814 | 10363181 | 6 | Product used for unknown indication |
| 103631814 | 10363181 | 7 | Product used for unknown indication |
| 103631814 | 10363181 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103631814 | 10363181 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103631814 | 10363181 | Fall | |
| 103631814 | 10363181 | Fibula fracture | |
| 103631814 | 10363181 | Pain | |
| 103631814 | 10363181 | Pyrexia | |
| 103631814 | 10363181 | Tibia fracture | |
| 103631814 | 10363181 | Wrist fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103631814 | 10363181 | 1 | 20130729 | 0 |